
Title: Senior Scientist, Bioinformatics
Reports to: Director, Bioinformatics
Location: Redwood City, CA
Classification: Exempt
Coherus Oncology is seeking a Senior Scientist, Bioinformatics to join the Translational Medicine team and support the analysis and interpretation of translational and clinical biomarker data from oncology clinical trials.
This is a hands-on bioinformatics role for an industry-experienced scientist who enjoys working close to the data, biology, and clinical context. The Senior Scientist will execute rigorous, reproducible analyses and collaborate closely with translational scientists and other cross-functional partners to generate biologically meaningful insights that support clinical decision-making.
Within a small, highly collaborative team, this role focuses on direct analytical contributions to active clinical programs and provides meaningful exposure to translational bioinformatics in a clinical-stage biotech environment.
Responsibilities
Education & Expereience:
Required Skills:
Preferred Skills:
The Base Salary Range for this position is $140,000 to $175,000. Coherus considers various factors, including professional background and work experience, when determining base pay. These considerations mean actual compensation will vary.
Coherus provides equal employment opportunities to all employees and applicants for employment and prohibits unlawful discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws. We also prohibit discrimination based on the perception that anyone has any of these characteristics or is associated with a person who has or is perceived as having any of these characteristics.

Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a promising pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Our strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both our pipeline candidates as well as our industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents.
If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities.